| Issue Date | Title | Author(s) |
| 1 | 29-Jun-2015 | Anti-proliferative, apoptotic and signal transduction effects of hesperidin in non-small cell lung cancer cells | Çinçin, Zeynep Birsu; Ünlü, Miray ; Kıran, Bayram; Bireller, Elif Sinem; Baran, Yusuf ; Çakmakoğlu, Bedia |
| 2 | Oct-2015 | Nilotinib does not alter the secretory functions of carotid artery endothelial cells in a prothrombotic or antithrombotic fashion | Katgı, Abdullah; Sevindik, Ömer Gökmen; Adan Gökbulut, Aysun ; Özsan, Güner Hayri; Yüksel, Faize; Solmaz, Şerife Medeni; Alacacıoğlu, İnci; Özcan, Mehmet Ali; Demirkan, Fatih; Baran, Yusuf ; Pişkin, Özden |
| 3 | 2015 | A novel natural product, KL-21, inhibits proliferation and induces apoptosis in chronic lymphocytic leukemia cells | Adan Gökbulut, Aysun ; Yaşar, Mustafa; Baran, Yusuf |
| 4 | Nov-2015 | The pleiotropic effects of fisetin and hesperetin on human acute promyelocytic leukemia cells are mediated through apoptosis, cell cycle arrest, and alterations in signaling networks | Adan, Aysun ; Baran, Yusuf |
| 5 | Sep-2015 | Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted “hsa-miR-2278” as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A | Tezcanlı Kaymaz, Burçin; Selvi Günel, Nur; Ceyhan, Metin; Bozok Çetintaş, Vildan; Özel, Buket; Kartal Yandım, Melis; Kıpçak, Sezgi; Aktan, Çağdaş; Adan Gökbulut, Aysun ; Baran, Yusuf ; Kosova Can, Buket |
| 6 | Mar-2015 | Targeting FoxM1 transcription factor in T-cell acute lymphoblastic leukemia cell line | Tüfekçi, Özlem; Kartal Yandım, Melis; Ören, Hale; İrken, Gülersu; Baran, Yusuf |
| 7 | Dec-2015 | An update on molecular biology and drug resistance mechanisms of multiple myeloma | Mutlu, Pelin; Kiraz, Yağmur ; Gündüz, Ufuk; Baran, Yusuf |
